Clinical impact of spine magnetic resonance imaging as a valuable prognostic tool for patients with multiple myeloma: a retrospective study

被引:2
作者
Lee, Jung Min [1 ]
Cho, Hee Jeong [1 ]
Moon, Joon-Ho [1 ]
Sohn, Sang Kyun [1 ]
Park, Byunggeon [2 ]
Baek, Dong Won [1 ,3 ]
机构
[1] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu, South Korea
[2] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Radiol, Daegu, South Korea
[3] Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Hosp, Dept Hematol Oncol, 130 Dongdeok Ro, Taegu 700721, South Korea
来源
JOURNAL OF YEUNGNAM MEDICAL SCIENCE | 2022年 / 39卷 / 04期
关键词
Hematopoietic stem cell transplantation; Magnetic resonance imaging; Multiple myeloma; Prognosis; BONE-MARROW; WHOLE-BODY; DIAGNOSIS; THERAPY; DISEASE; MRI; TRANSPLANTATION; DEXAMETHASONE; CHEMOTHERAPY; BORTEZOMIB;
D O I
10.12701/jyms.2021.01648
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study investigated the prognostic impact of spine magnetic resonance imaging (MRI) in patients newly diagnosed Methods: We retrospectively evaluated 214 patients who were newly diagnosed with MM between March 2015 and December 2019. The patients were classified into five different infiltration patterns based on spine MRI as follows: (1) normal appearance, (2) focal, (3) diffuse, (4) combined focal and diffuse infiltration, and (5) "salt-and-pepper." Results: Forty patients (18.7%) showed a normal appearance, whereas focal, diffuse, combined focal and diffuse infiltration, and "saltand-pepper" patterns were identified in 68 (31.8%), 40 (18.7%), 52 (24.3%), and 14 patients (6.5%), respectively. The patients with normal and "salt-and-pepper" patterns were younger than patients with other patterns (median age, 61.6 vs. 66.8 years; p=0.001). Moreover, 63% and 59.3% of patients with normal and "salt-and-pepper" patterns were scored International Staging System (ISS) stage I and revised ISS (R-ISS) stage I, respectively, whereas only 12.5% of patients with other patterns were scored ISS stage I and R-ISS stage I. Patients with normal and "salt-and-pepper" patterns had a better prognosis than those with other patterns, whereas relapse and death rates were significantly higher in patients with focal, diffuse, and combined MRI patterns.Conclusion: Characteristic MRI findings have a significant prognostic value for long-term survival in patients newly diagnosed with MM. In particular, focal, diffuse, and combined focal and diffuse infiltration patterns are unfavorable prognostic factors.
引用
收藏
页码:300 / 308
页数:9
相关论文
共 31 条
  • [1] Extent of Disease Burden Determined With Magnetic Resonance Imaging of the Bone Marrow Is Predictive of Survival Outcome in Patients With Multiple Myeloma
    Ailawadhi, Sikander
    Abdelhalim, Ahmed N.
    Derby, Lyudmyla
    Mashtare, Terry L.
    Miller, Kena C.
    Wilding, Gregory E.
    Alberico, Ronald A.
    Gottlieb, Ronald
    Klippenstein, Donald L.
    Lee, Kelvin
    Chanan-Khan, Asher A.
    [J]. CANCER, 2010, 116 (01) : 84 - 92
  • [2] Attal M, 1996, N Engl J Med
  • [3] Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Importance of Whole-Body versus Spinal MR Imaging
    Baeuerle, Tobias
    Hillengass, Jens
    Fechtner, Kerstin
    Zechmann, Christian M.
    Grenacher, Lars
    Moehler, Thomas M.
    Heiss, Christiane
    Wagner-Gund, Barbara
    Neben, Kai
    Kauczor, Hans-Ulrich
    Goldschmidt, Hartmut
    Delorme, Stefan
    [J]. RADIOLOGY, 2009, 252 (02) : 477 - 485
  • [4] Whole-body MRI versus whole-body MDCT for staging of multiple myeloma
    Baur-Melnyk, Andrea
    Buhmann, Sonja
    Becker, Christoph
    Schoenberg, Stefan Oswald
    Lang, Nicola
    Bartl, Reiner
    Reiser, Maximilian Ferdinand
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 190 (04) : 1097 - 1104
  • [5] Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications
    Cardona-Benavides, Ignacio J.
    de Ramon, Cristina
    Gutierrez, Norma C.
    [J]. CELLS, 2021, 10 (02) : 1 - 28
  • [6] Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
    Cavo, Michele
    Tacchetti, Paola
    Patriarca, Francesca
    Petrucci, Maria Teresa
    Pantani, Lucia
    Galli, Monica
    Di Raimondo, Francesco
    Crippa, Claudia
    Zamagni, Elena
    Palumbo, Antonio
    Offidani, Massimo
    Corradini, Paolo
    Narni, Franco
    Spadano, Antonio
    Pescosta, Norbert
    Deliliers, Giorgio Lambertenghi
    Ledda, Antonio
    Cellini, Claudia
    Caravita, Tommaso
    Tosi, Patrizia
    Baccarani, Michele
    [J]. LANCET, 2010, 376 (9758) : 2075 - 2085
  • [7] High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
    Child, JA
    Morgan, GJ
    Davies, FE
    Owen, RG
    Bell, SE
    Hawkins, K
    Brown, J
    Drayson, MT
    Selby, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (19) : 1875 - 1883
  • [8] Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma
    Delgado-Calle, Jesus
    Anderson, Judith
    Cregor, Meloney D.
    Hiasa, Masahiro
    Chirgwin, John M.
    Carlesso, Nadia
    Yoneda, Toshiyuki
    Mohammad, Khalid S.
    Plotkin, Lilian I.
    Roodman, G. David
    Bellido, Teresita
    [J]. CANCER RESEARCH, 2016, 76 (05) : 1089 - 1100
  • [9] Delorme S, 2011, RECENT RESULTS CANC, V183, P133, DOI 10.1007/978-3-540-85772-3_7
  • [10] International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
    Dimopoulos, M.
    Terpos, E.
    Comenzo, R. L.
    Tosi, P.
    Beksac, M.
    Sezer, O.
    Siegel, D.
    Lokhorst, H.
    Kumar, S.
    Rajkumar, S. V.
    Niesvizky, R.
    Moulopoulos, L. A.
    Durie, B. G. M.
    [J]. LEUKEMIA, 2009, 23 (09) : 1545 - 1556